JP2023549341A5 - - Google Patents
Info
- Publication number
- JP2023549341A5 JP2023549341A5 JP2023527451A JP2023527451A JP2023549341A5 JP 2023549341 A5 JP2023549341 A5 JP 2023549341A5 JP 2023527451 A JP2023527451 A JP 2023527451A JP 2023527451 A JP2023527451 A JP 2023527451A JP 2023549341 A5 JP2023549341 A5 JP 2023549341A5
- Authority
- JP
- Japan
- Prior art keywords
- pyrazino
- piperidine
- methyl
- hydroxyphenyl
- dione
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063110688P | 2020-11-06 | 2020-11-06 | |
| US63/110,688 | 2020-11-06 | ||
| PCT/US2021/058424 WO2022099117A1 (en) | 2020-11-06 | 2021-11-08 | Brm targeting compounds and associated methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023549341A JP2023549341A (ja) | 2023-11-24 |
| JP2023549341A5 true JP2023549341A5 (cg-RX-API-DMAC10.html) | 2024-11-18 |
Family
ID=81456756
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023527451A Pending JP2023549341A (ja) | 2020-11-06 | 2021-11-08 | Brm標的化化合物及び関連する使用方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US12448389B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4240743A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2023549341A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20230117577A (cg-RX-API-DMAC10.html) |
| CN (1) | CN116745295A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2021376415A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3200685A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL302669A (cg-RX-API-DMAC10.html) |
| MX (1) | MX2023005301A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2022099117A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT4161935T (pt) * | 2020-06-09 | 2025-08-14 | Prelude Therapeutics Inc | Compostos direcionados a brm e métodos de utilização associados |
| US20240024488A1 (en) * | 2020-11-20 | 2024-01-25 | Foghorn Therapeutics Inc. | Compounds and uses thereof |
| CA3211347A1 (en) | 2021-03-19 | 2022-09-22 | Erika Araujo | Indazole based compounds and associated methods of use |
| JP2024539269A (ja) * | 2021-10-22 | 2024-10-28 | グルータクス セラピューティクス (シャンハイ) カンパニー、リミテッド | Crbn e3リガーゼリガンド化合物、当該リガンド化合物に基づいて開発したタンパク質分解剤及びそれらの応用 |
| PL4245756T3 (pl) * | 2022-03-17 | 2025-02-17 | Gilead Sciences, Inc. | Środki degradujące palec cynkowy z rodziny ikaros i ich zastosowania |
| JP2025521091A (ja) * | 2022-05-10 | 2025-07-08 | プレリュード・セラピューティクス・インコーポレイテッド | がんの治療のためのsmarca4タンパク質分解因子としての6,6a,7,8,9,10-ヘキサヒドロ-5h-ピラジノ[1’,2’:4,5]ピラジノ[2,3-c]ピリダジン誘導体 |
| EP4587127A1 (en) * | 2022-09-15 | 2025-07-23 | Prelude Therapeutics Incorporated | Brm targeting compounds and associated methods of use |
| US20240190886A1 (en) * | 2022-11-15 | 2024-06-13 | Prelude Therapeutics Incorporated | BRM Targeting Compounds and Associated Methods of Use |
| WO2024192064A1 (en) * | 2023-03-14 | 2024-09-19 | Oncopia Therapeutics, Inc. D/B/A/ Proteovant Therapeutics, Inc. | Compounds and compositions as smarca2/4 degraders and uses thereof |
| CN120957992A (zh) * | 2023-04-07 | 2025-11-14 | 南京再明医药有限公司 | Brm选择性降解剂化合物 |
| EP4695250A1 (en) | 2023-04-12 | 2026-02-18 | Aurigene Oncology Limited | Tetracyclic compounds as smarca2 and/or smarca4 degraders |
| AU2024304006A1 (en) * | 2023-06-16 | 2026-01-08 | Plexium, Inc. | Compounds and pharmaceutical compositions that degrade swi/snf-related matrix-associated actin-dependent regulator of chromatin subfamily a |
| AU2024352092A1 (en) | 2023-09-28 | 2026-04-09 | Arvinas Operations, Inc. | Benzimidazole and benzimidazolone based protac compounds for the targeted degradation of leucine rich repeat kinase 2 (lrrk2) |
| WO2025101738A1 (en) * | 2023-11-07 | 2025-05-15 | Prelude Therapeutics Incorporated | Brm targeting compounds and associated methods of use |
| WO2025106482A1 (en) * | 2023-11-13 | 2025-05-22 | Oncopia Therapeutics, Inc. D/B/A Sk Life Science Labs | Compounds and compositions as smarca2/4 degraders and uses thereof |
| WO2025106472A1 (en) * | 2023-11-13 | 2025-05-22 | Regents Of The University Of Michigan | Compounds and compositions as smarca2/4 degraders and uses thereof |
| WO2025113460A1 (zh) * | 2023-11-28 | 2025-06-05 | 西藏海思科制药有限公司 | 一种哒嗪并三环衍生物及其在医药上的应用 |
| AU2024411627A1 (en) * | 2023-12-26 | 2026-07-16 | Gluetacs Therapeutics (Shanghai) Co., Ltd. | Compounds with two azaheterocycles substituted isoindolinone skeleton and uses thereof |
| WO2025184459A1 (en) * | 2024-03-01 | 2025-09-04 | Prelude Therapeutics Incorporated | Brm and brg1 targeting compounds and associated methods of use |
| WO2025193454A1 (en) | 2024-03-01 | 2025-09-18 | Prelude Therapeutics Incorporated | Brm and brg1 targeting antibody-drug conjugates and methods of use thereof |
| WO2025194405A1 (en) * | 2024-03-21 | 2025-09-25 | Prelude Therapeutics Incorporated | Polymorphic smarca inhibitors and uses thereof |
| WO2026098598A1 (zh) * | 2024-11-08 | 2026-05-15 | 正大天晴药业集团股份有限公司 | 含有三并杂环的化合物 |
| WO2026136866A1 (en) | 2024-12-20 | 2026-06-25 | Prelude Therapeutics Incorporated | Kat6 targeting compounds |
| WO2026151924A1 (en) * | 2025-01-09 | 2026-07-16 | Triana Biomedicines, Inc. | 2-(2, 6-dioxopiperidine-3-yl)-1, 3-dioxoisoindoline derivatives bearing an heteroaryl group as anaplastic lymphoma kinase (alk) degraders and uses thereof |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3657744A (en) | 1970-05-08 | 1972-04-25 | Univ Minnesota | Method for fixing prosthetic implants in a living body |
| US4733665C2 (en) | 1985-11-07 | 2002-01-29 | Expandable Grafts Partnership | Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft |
| US5023252A (en) | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
| US5040548A (en) | 1989-06-01 | 1991-08-20 | Yock Paul G | Angioplasty mehtod |
| US5350395A (en) | 1986-04-15 | 1994-09-27 | Yock Paul G | Angioplasty apparatus facilitating rapid exchanges |
| US5061273A (en) | 1989-06-01 | 1991-10-29 | Yock Paul G | Angioplasty apparatus facilitating rapid exchanges |
| US4748982A (en) | 1987-01-06 | 1988-06-07 | Advanced Cardiovascular Systems, Inc. | Reinforced balloon dilatation catheter with slitted exchange sleeve and method |
| US5001139A (en) | 1987-06-12 | 1991-03-19 | American Cyanamid Company | Enchancers for the transdermal flux of nivadipine |
| US4992445A (en) | 1987-06-12 | 1991-02-12 | American Cyanamid Co. | Transdermal delivery of pharmaceuticals |
| CA1322628C (en) | 1988-10-04 | 1993-10-05 | Richard A. Schatz | Expandable intraluminal graft |
| US6344053B1 (en) | 1993-12-22 | 2002-02-05 | Medtronic Ave, Inc. | Endovascular support device and method |
| US5674278A (en) | 1989-08-24 | 1997-10-07 | Arterial Vascular Engineering, Inc. | Endovascular support device |
| US5292331A (en) | 1989-08-24 | 1994-03-08 | Applied Vascular Engineering, Inc. | Endovascular support device |
| JP6815318B2 (ja) * | 2014-12-23 | 2021-01-20 | ダナ−ファーバー キャンサー インスティテュート,インコーポレイテッド | 二官能性分子によって標的化タンパク質分解を誘導する方法 |
| GB2554071A (en) | 2016-09-14 | 2018-03-28 | Univ Dundee | Small molecules |
| SI3526202T1 (sl) | 2016-10-11 | 2025-04-30 | Arvinas Operations, Inc. | Spojine in postopki za ciljno razgradnjo androgenskih receptorjev |
| IL266842B (en) | 2016-12-01 | 2022-09-01 | Arvinas Operations Inc | History of tetrahydronaphthalene and tetrahydroisoquinoline as estrogen receptor antagonists |
| WO2019084026A1 (en) | 2017-10-24 | 2019-05-02 | Genentech, Inc. | (4-HYDROXYPYRROLIDIN-2-YL) -HETEROCYCLIC COMPOUNDS AND METHODS OF USE |
| WO2019084030A1 (en) | 2017-10-24 | 2019-05-02 | Genentech, Inc. | (4-HYDROXYPYRROLIDIN-2-YL) -HYDROXAMATE COMPOUNDS AND METHODS OF USE |
| AU2019249849C1 (en) | 2018-04-01 | 2022-09-29 | Arvinas Operations, Inc. | BRM targeting compounds and associated methods of use |
| SG11202104495YA (en) * | 2018-04-26 | 2021-05-28 | Aurigene Discovery Tech Ltd | Pyridazine derivatives as smarca2/4 degraders |
| WO2019213005A1 (en) * | 2018-04-30 | 2019-11-07 | Dana-Farber Cancer Institute, Inc. | Small molecule degraders of polybromo-1 (pbrm1) |
| US12454520B2 (en) * | 2018-07-06 | 2025-10-28 | Kymera Therapeutics, Inc. | Protein degraders and uses thereof |
| EP3867242A1 (en) | 2018-10-15 | 2021-08-25 | Nurix Therapeutics, Inc. | Bifunctional compounds for degrading btk via ubiquitin proteosome pathway |
| WO2021133917A1 (en) * | 2019-12-23 | 2021-07-01 | Kymera Therapeutics, Inc. | Smarca inhibitors and uses thereof |
| PT4161935T (pt) * | 2020-06-09 | 2025-08-14 | Prelude Therapeutics Inc | Compostos direcionados a brm e métodos de utilização associados |
| JP2025521091A (ja) * | 2022-05-10 | 2025-07-08 | プレリュード・セラピューティクス・インコーポレイテッド | がんの治療のためのsmarca4タンパク質分解因子としての6,6a,7,8,9,10-ヘキサヒドロ-5h-ピラジノ[1’,2’:4,5]ピラジノ[2,3-c]ピリダジン誘導体 |
-
2021
- 2021-11-08 WO PCT/US2021/058424 patent/WO2022099117A1/en not_active Ceased
- 2021-11-08 KR KR1020237018973A patent/KR20230117577A/ko active Pending
- 2021-11-08 AU AU2021376415A patent/AU2021376415A1/en active Pending
- 2021-11-08 IL IL302669A patent/IL302669A/en unknown
- 2021-11-08 JP JP2023527451A patent/JP2023549341A/ja active Pending
- 2021-11-08 US US17/521,195 patent/US12448389B2/en active Active
- 2021-11-08 CA CA3200685A patent/CA3200685A1/en active Pending
- 2021-11-08 CN CN202180087475.7A patent/CN116745295A/zh active Pending
- 2021-11-08 MX MX2023005301A patent/MX2023005301A/es unknown
- 2021-11-08 EP EP21816605.6A patent/EP4240743A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7313354B2 (ja) | Tlr阻害剤として有用なアミド置換されたインドール化合物 | |
| US12448389B2 (en) | BRM targeting compounds and associated methods of use | |
| TWI689510B (zh) | 4-氮雜吲哚化合物 | |
| AU2015261812B2 (en) | 5-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds which are JAK inhibitors | |
| US20240245681A1 (en) | Heterocyclic derivatives useful as shp2 inhibitors | |
| JP5788415B2 (ja) | Cdk4/6阻害剤としてのピロロピリミジン化合物 | |
| CN113795483A (zh) | 作为shp2拮抗剂的甲酰胺-嘧啶衍生物 | |
| IL280331B2 (en) | Heterobicyclic compounds for inhibiting the activity of shp2 | |
| AU2018239542A1 (en) | Novel heterocyclic derivatives useful as SHP2 inhibitors | |
| KR20200100760A (ko) | 디아자인돌 화합물 | |
| EP3661934A1 (en) | [1,2,4]TRIAZOLO[4,3-a]PYRIDINYL SUBSTITUTED INDOLE COMPOUNDS | |
| KR20200100687A (ko) | 치환된 인돌 에테르 화합물 | |
| TW202330548A (zh) | 用於降解egfr激酶的化合物 | |
| CN116981661A (zh) | 稠环取代的六元杂环化合物及其制法和用途 | |
| US12091426B2 (en) | Bifunctional degraders of hematopoietic progenitor kinase and therapeutic uses thereof | |
| EP4051388A1 (en) | Substituted pyrazole compounds as toll receptor inhibitors | |
| JP6454346B2 (ja) | 芳香族複素環式化合物及び医薬におけるその応用 | |
| JP2025530791A (ja) | トリアジン化合物及びその使用 | |
| WO2025253326A1 (ko) | Kras 저해제로서 신규한 3환 화합물 및 이의 용도 | |
| RU2014144285A (ru) | Карбоксамидные соединения и их применение в качестве ингибиторов кальпаина v | |
| JP2015512427A5 (cg-RX-API-DMAC10.html) | ||
| US20250235456A1 (en) | Methods of use for aza-quinazoline compounds | |
| CN115557946A (zh) | 杂环内酰胺类化合物,包含其的药物组合物及其用途 | |
| EA052189B1 (ru) | Соединения, нацеленные на brm, и связанные с ними способы использования |